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Abstract
Giardia lamblia is an intestinal protozoan parasite that causes giardiasis, a disease of high prevalence in Latin America, Asia and Africa.
Giardiasis leads to poor absorption of nutrients, severe electrolyte loss and growth retardation. In addition to its clinical importance, this
parasite is of special biological interest due to its basal evolutionary position and simplified metabolism, which has not been studied thoroughly.
One of the most important and conserved metabolic pathways is the biosynthesis of nicotinamide adenine dinucleotide (NAD). This molecule
is widely known as a coenzyme in multiple redox reactions and as a substrate in cellular processes such as synthesis of Ca2+ mobilizing
agents, DNA repair and gene expression regulation. There are two pathways for NAD biosynthesis, which converge at the step catalyzed
by nicotinamide/nicotinate mononucleotide adenylyltransferase (NMNAT, EC 2.7.7.1/18). Using bioinformatics tools, we found two NMNAT
sequences in Giardia lamblia (glnmnat-a and glnmnat-b). We first verified the identity of the sequences in silico. Subsequently, glnmnat-a
was cloned into an expression vector. The recombinant protein (His-GlNMNAT) was purified by nickel-affinity binding and was used in
direct in vitro enzyme assays assessed by C18-HPLC, verifying adenylyltransferase activity with both nicotinamide (NMN) and nicotinic acid
(NAMN) mononucleotides. Optimal reaction pH and temperature were 7.3 and 26 °C. Michaelis–Menten kinetics were observed for NMN
and ATP, but saturation was not accomplished with NAMN, implying low affinity yet detectable activity with this substrate. Double-reciprocal
plots showed no cooperativity for this enzyme. This represents an advance in the study of NAD metabolism in Giardia spp.
© 2015 Published by Elsevier B.V. on behalf of Société Française de Biochimie et Biologie Moléculaire (SFBBM).
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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u. Introduction
Nicotinamide adenine dinucleotide (NAD) is a key molecule
n cellular metabolism [1]. Its central role as a coenzyme in
EDOX reactions has been known since its function as an ac-
Abbreviations: QAPRT, quinolinic acid phosphoribosyltransferase;
APRT, nicotinic acid phosphoribosyltransferase; NAMPRT, nicotinamide
hosphoribosyltransferase; NRK, nicotinamide riboside kinase; NMNAT,
icotinamide/nicotinic acid mononucleotide adenylyltransferase; NAD syn-
hetase, EC. 6.3.5.1; QA, quinolinic acid; NA, nicotinic acid; NAM, nicoti-
amide; NR, nicotinamide riboside; NAMN, nicotinic acid mononucleotide;
MN, nicotinamide mononucleotide; NAAD, nicotinic acid adenine dinu-
leotide; NAD, nicotinamide adenine dinucleotide.
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nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.eptor and donor of hydride ions was established [2], which is
n essential characteristic for the maintenance of cellular RE-
OX balance and energy production. In addition, NAD is used
s substrate in non-REDOX reactions, e.g., deacetylation by sir-
uins [3], mono and poly-ADP-ribosylation [4,5] and the syn-
hesis of key second messengers in Ca2+ mobilization such as
icotinic acid-adenine dinucleotide phosphate (NAADP), cyclic
DP-ribose (cADP), ADP-ribose (ADPR) [6] and O-acetyl-
DP-ribose (OAADPR) [7]. These non-REDOX reactions are
art of fundamental cellular processes, e.g., gene expression reg-
lation, DNA repair, chromatin stability, calcium mobilization,
ircadian rhythm control and cell death [2,8]. When used as a
oenzyme in oxidation–reduction reactions, NAD exists in its
xidized form NAD+ and in its reduced form NADH, maintain-
ng a constant concentration. However, in non-REDOX reactionsBiochimie et Biologie Moléculaire (SFBBM). This is an open access article
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ain which NAD undergoes chemical breakdown, it is consumed,
reducing its concentration.
Given this scenario, the cell must have NAD biosynthetic
pathways to maintain a constant source of this molecule. There
are two main NAD biosynthetic pathways (Fig. 1): one de novo
pathway from quinolinic acid (QA) and a salvage pathway from
nicotinamide (NAM), nicotinic acid (NA) and nicotinamide ri-
boside (NR). Both the de novo pathway and the salvage path-
way converge in NMNAT catalytic activity, which involves the
Mg2+-dependent reversible condensation [9,10] of ATP with
NMN (nicotinamide mononucleotide) or NAMN (nicotinate
mononucleotide), producing NAD (nicotinamide adenine din-
ucleotide) or NAAD (nicotinate adenine dinucleotide), respec-
tively [11]. Ubiquitous in nature, this enzyme has been found
in all organisms from all three kingdoms of life (archaea, eu-
bacteria, eukaryotes) in which it has been sought, justifying the
importance of its function in the cell.
The present study aims to examine NAD metabolism in the
parasitic protozoan pathogen Giardia lamblia (also called Gia-
rdia intestinalis or Giardia duodenalis) through the identifica-Fig. 1. Representation of NAD biosynthesis. Enzymes involved are de-
noted by numbers: 1. QAPRT (quinolinic acid phosphoribosyltransferase, EC.
2.4.2.19). 2. NAPRT (nicotinic acid phosphoribosyltransferase, EC. 2.4.2.11).
3. Nicotinamidase (EC. 3.5.1.19). 4. NAMPRT (nicotinamide phosphoribo-
syltransferase, EC. 2.4.2.12). 5. NRK (nicotinamide riboside kinase, EC.
2.7.1.22). 6. NMNAT (nicotinamide/nicotinic acid mononucleotide adenylyl-
transferase, EC. 2.7.7.1/18). 7. NAD synthetase (EC. 6.3.5.1). Images drawn
with ChemSketch Freeware (ACD/Labs v14.01).
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Eion, cloning, expression, purification and enzymatic validation
f nicotinamide/nicotinate mononucleotide adenylyltransferase
NMNAT), which was identified using bioinformatics tools.
. Materials and methods
.1. Identification and bioinformatic validation of the
utative sequence
Multiple sequence alignment of 16 NMNAT sequences re-
orted in the UniProtKB database (http://www.uniprot.org/) was
erformed using the MUSCLE [12,13] algorithm in the CLC
equence Viewer v6.9 (Additional Alignments plugin v.1.4.5)
rogram. The resulting consensus sequence of 244 aa was used
o search the GiardiaDB [14] (http://giardiadb.org/giardiadb/)
sing the BLAST algorithm. The sequences with the highest
core and lowest E-value were subsequently validated by find-
ng conserved domains and their putative function. Addition-
lly, a 3-dimensional model of the putative protein was obtained
I-TASSER server [15,16]) to compare it with the structure of
rystallized and reported NMNATs.
.2. Culture of Giardia lamblia
Parasites (WB clone C6) were cultured in borosilicate tubes
t 37 °C in TYI-S-33 medium (Diamond, 1978). Subsequently,
he parasites were separated from the medium by centrifugation
1500 rpm, 10 min) and washed three times with cold sterile
BS. The washed parasites were resuspended in 6 mL of sterile
BS and counted in a Neubauer chamber. The parasites were
entrifuged again, and the resultant pellet was stored at −20 °C
o subsequently extract genomic DNA [17].
.3. Genomic DNA extraction
Cells (7.5 × 107) were resuspended in 200μL of sterile PBS.
rom these cells, genomic DNA was extracted using an Easy-
NATM kit (Invitrogen). The extracted DNA was resuspended
n 100μL of TE buffer and stored at 4 °C. Purity and concentra-
ion were evaluated by a UV–Vis spectrophotometer (Spectronic
enesys 5) at 260 and 280 nm.
.4. PCR amplification of the coding region
The NMNAT coding region of Giardia lamblia was am-
lified from genomic DNA using the following primers:
’-caccATGCCCTGTCCGCCGGT-3′(forward) and 5′-
TATTGGAAACTAGGGGGTG-3 (reverse). The amplifi-
ation conditions were as follows: 3 mM MgCl2, 0.5 μM
rimers, 0.2 mM dNTPs, 2.5 U of Taq polymerase (Amplitaq)
nd 100 ng of gDNA template. PCR was performed in a final
olume of 25 μL in a GeneAmp® PCR system 2400 Perkin
lmerTM thermal cycler. The optimal thermal cycle used was
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Table 1
Reaction mixture for enzyme assays.
Reagent Volume (μL) Final concentration
HEPES-KOH pH 7.5 (100 mM)/
MgCl2 (40 mM)
25.0 25 mM/10 mM
ATP (12.5 mM) 10.5 1.31 mM
NMN/NAMN (50 mM) 2.5 1.25 mM
His-GlNMNATa 62.0 60 ng/μL
a For the positive control, His-HsNMNAT-3 was used (final concentration
in reaction mix: 25 ng/uL). For the negative control, soluble fraction of non-
transformed E. coli B21 (DE3) cells was used.
a
d
e
T
a
w
v
a
B
2
e
T
s
m
a
p
P
c
2
fi
T
c
U
2
2
T
c
2
a
c
c
c
p
p
i
L
w
(
e
q
r
b
2
a
i
r
(
T
F
p
ps follows: initial denaturation (94 °C, 5 min) followed by 30
enaturation cycles (94 °C, 45 s), annealing (55 °C, 45 s), and
xtension (72 °C, 1 min) and a final extension at 72 °C for 7 min.
he PCR product was evaluated by horizontal electrophoresis in
1.5% agarose gel in 0.5X TBE buffer. Staining was performed
ith 0.05% ethidium bromide for 20 min [18]. The gel was
isualized on a Molecular Imager® Gel DocTM XR image
nalyzer including Quantity One Basic 4.6.3 software from
IO-RADTM.
.5. Cloning of the amplified coding region into an
xpression vector
The PCR product (glnmnat) was ligated into a pET100/D-
OPO® vector (ChampionTM pET Directional TOPO® Expres-
ion Kits from InvitrogenTM). The resulting recombinant plas-
id (pET100/D-TOPO-glnmnat) was transformed by heat shock
t 42 °C into competent E. coli cells (OneShot® TOP10 Com-
etent Cells) [18]. The transformation was confirmed by colony
CR using the primers and thermal program previously indi-
ated.
.6. Expression vector purification
The pET100/D-TOPO-glnmnat expression vector was puri-
ed from a 5-mL culture (LB medium + ampicillin) of E. coliig. 2. Multiple sequence alignment of 16 homologous NMNAT proteins from
ercentage of conservation is displayed throughout the sequence in bars. Alignmen
rogram (CLCBio A/S, Additional Alignments plugin v.1.5.1).OP10 cells previously transformed by the alkaline lysis pro-
edure [18]. Purity and concentration were evaluated using a
V–Vis spectrophotometer (Spectronic Genesys 5) at 260 and
80 nm.
.7. Transformation into expression strains
The previously extracted recombinant plasmid pET100/D-
OPO-glnmnat was transformed into chemically competent E.
oli BL21 cells (Invitrogen) by heat shock at 42 °C [18].
.8. Expression of the recombinant protein His-GlNMNAT
Isopropyl-β-D-1-thiogalactopyranoside (IPTG) was added to
250-mL culture of E. coli BL21 (OD600nm = 0.550) for a final
oncentration of 1 mM. Induction was performed at 20 °C with
onstant stirring for 20 h. After the induction, the culture was
entrifuged at 6000 rpm for 10 min at 4 °C, obtaining a bacterial
ellet with a wet weight of 1.96 g. The bacterial pellet was resus-
ended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM
midazole, pH 8.0) with 5 mL of buffer per gram of wet solid.
ysozyme was added to a final concentration of 1 mg/mL, as
ell as ribonuclease (Promega) and protease inhibitor cocktail
Sigma, P8340) at a dilution of 1:400. The mixture was homog-
nized by vortex stirring and incubated at 4 °C for 2 h. Subse-
uently, 6 ultrasonic pulses were applied for 15 s followed by a
est of 15 s. The soluble and insoluble fractions were separated
y centrifugation at 12,000 rpm for 20 min at 4 °C [18].
.9. SDS-PAGE and immunoblotting
The soluble and insoluble cell lysate fractions were evalu-
ted by 12% polyacrylamide gel electrophoresis under denatur-
ng conditions (SDS-PAGE) (Coomassie blue staining) [18]. A
eplica of the gel was transferred to a nitrocellulose membrane
0.45 μm thick; ThermoScientific) in transfer buffer (25 mM
ris base, 192 mM glycine, and 10% methanol v/v) at 200 mAphylogenetically divergent organisms with GlNMNAT isoenzymes. The
t was done with the ClustalO algorithm in the CLC Sequence Viewer v7.0.2
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1
e
1for 2 h. The membrane was blocked overnight with a 5% w/v
skim milk solution in TBST. Immunodetection of the recombi-
nant protein was performed using a histidine tag with the primary
antibody anti-His-mAb (1:3000, Amersham) and secondary an-
tibody anti-mAb-HRP (1:2000); 4-chloro-naphthol (Sigma) and
hydrogen peroxide were used as developing agents [19].Fig. 3. Alignment between the three NMNAT human isoenzymes and the two
residue position is observed in pink bars. The multiple alignment was done with
Alignments plugin v.1.5.1). Identity percentages calculated with BLASTP algor
recognition and binding in N-terminus and C-terminus regions depicted in red (G
of the references to colour in this figure legend, the reader is referred to the web.10. Nickel-affinity purification
Nickel-affinity resin solution (Ni-NTA, Qiagen) was used at
00 μL per milliliter of soluble protein extract. The resin was
quilibrated in lysis buffer (50 mM NaH2PO4, 300 mM NaCl,
0 mM imidazole, pH 8.0) and incubated with soluble extractNMNAT isoenzymes from Giardia lamblia. Conservation percentage per
ClustalO (CLC Sequence Viewer v7.0.2 program, CLCBio A/S, Additional
ithm (NCBI) and shown in the adjacent table. ATP active site motif for
xFxPx[H/T]xxH) and violet respectively (ISSTxxR) [10]. (For interpretation
version of this article.)
N. Forero-Baena et al. /Biochimie Open 1 (2015) 61–69 65
Fig. 4. GlNMNAT tertiary structure model. (A) Three-dimensional GlNMNAT model (I-TASSER [15,16]). A Rossmann-type fold, characteristic of
nucleotide-binding proteins, is observed. C-score: −5 < 0.95 < 2. TM-score: 0.84 ± 0.08 > 0.5. RMSD: 3.7 ± 2.5 ˚A. (B) Overlay of the model with
the structure of the HsNMNAT-3 protein (1nuq_A [9], 252 aa, in yellow). Alignment performed with the UCSF Chimera v1.8 program [23]. RMSD between
171 atom pairs: 0.670 ˚A. Molecular graphics and analyses were performed with the UCSF Chimera package. (For interpretation of the references to colour
in this figure legend, the reader is referred to the web version of this article.)
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Fig. 5. Amplification of the NMNAT coding region of Giardia lamblia. (1)
Ladder 100 bp (fermentas). (2) Negative control (without DNA template). (3)
Amplification of glnmnat from genomic DNA. Agarose gel in 1.5% TBE,
ethidium bromide staining at 0.05%.vernight on ice; the supernatant with unbound proteins was
ollected by centrifugation at 3000 rpm for 3 min. Washes were
erformed with wash buffer (50 mM NaH2PO4, 300 mM NaCl,
0 mM imidazole, pH 8.0) to obtain an absorbance at 280 nm of
.000 ± 0005. The elution of the recombinant protein was per-
ormed with elution buffer (50 mM NaH2PO4, 300 mM NaCl,
ncreasing concentrations of imidazole 50 mM/80 mM/250 mM,
H 8.0) on ice overnight. Protein purification was verified by
DS-PAGE and western blotting under previously described
onditions [20].
.11. Evaluation of enzyme activity
An in vitro assay was conducted to determine the activity
f the purified recombinant protein (Table 1). For the negative
ontrol, the elution buffer was used instead of the recombinant
rotein eluate. For the positive control, an eluate with recombi-
ant Homo sapiens NMNAT-3 protein (His-HsNMNAT-3) was
sed. The mixtures were incubated at 37 °C for 30 min, af-
er which the reaction was stopped with 1.2 M HClO4 at 4 °C.
he protein was precipitated by centrifugation at 12,000 rpm for
min at 4 °C. The supernatant was neutralized with 1 M K2CO3
n ice. A total of 120 μL of supernatant was taken and diluted
o 240 μL with MQ H2O [21].
The resulting product of the in vitro reaction was eval-
ated by reverse phase HPLC. A Phenomenex Luna C18
250 mm×4.60 mm, 5μm) column was used. As mobile phases,
.12 M potassium phosphate buffer pH 6.0 and methanol were
sed. The separation was carried out in a gradient (0–8 min
0% buffer 20% water, 8–12 min 0–20% MeOH 80% buffer,
2–14 min 20% MeOH 80% buffer, 14–18 min 20% MeOH
0% buffer, 18–20 min 80% buffer 20% water) with a constant
ow of 1.5 mL/min, for 20 min per run. The analytes, whoseetention times were determined from standards, were detected
y spectrophotometry at 254.4 nm using a diode array detector
DAD).
.12. Determination of kinetic constants
Optimal reaction parameters (pH, °T and time) were deter-
ined. Then, NAD production rate was evaluated as a function
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Fig. 6. Expression of recombinant His-GlNMNAT. (A) SDS-PAGE, Coomassie blue staining. (B) Immunoblotting on nitrocellulose membrane. (1) Molecular
weight marker (MWM). (2) Uninduced BL21 cells. (3) Total cells induced. (4) Insoluble fraction. (5) Soluble fraction.
Fig. 7. Enrichment of His-GlNMNAT recombinant protein from the soluble fraction by nickel affinity. (A) SDS-PAGE, Coomassie blue staining. (B)
Immunoblotting on nitrocellulose membrane. (1) Molecular weight marker (MWM). (2) Soluble fraction. (3) Unbound proteins. (4) Wash 15. (5,6) Eluates
50 mM Imidazole. (7,8) Eluates 80 mM Imidazole. (9,10) Eluates 250 mM Imidazole.
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cof substrate concentrations (ATP, NMN and NAMN). For each
reaction, 1.9μg of recombinant GlNMNAT were used. ATP con-
centration window: 0.2, 0.5, 0.8, 1.2, 1.5, 2, 4, 6, 8 and 10 mM,
with NMN in excess (10 mM). NMN concentration window:
0.25, 0.5, 1, 2, 3, 4, 6 and 8 mM, with ATP in excess (10 mM).
NAMN concentration window: 0.25, 1, 2, 3, 4, 6, 8, 10 and
12 mM, with ATP in excess (10 mM). Triplicates were done for
each point in the windows. The data was processed by means
of non-linear (two-parameter rectangular hyperbola) and linear
regression (Hanes–Woolf). A double-reciprocal plot was made
to check if the enzyme had cooperativity.
3. Results and discussion
Fig. 2 shows a multiple sequence alignment of 16 NMNATs
of different organisms from which a consensus sequence of
244 aa was obtained. When searching with this sequence using
BLASTP in the GiardiaDB (Giardia Assemblage A isolate WB),
a sequence of 227 aa was found with a calculated size of 25.4 kDa
and encoded by a coding DNA sequence (CDS) of 684 bp
from chromosome 3 (Score: 75.5, E-Value: 2e-16, Gene ID:
GL50803_13672/XP_001704508.1/GI:159108475, no introns,
named GlNMNAT-A). Another sequence of 249 aa was identi-
fied, with a calculated size of 28.1 kDa and encoded by a CDS of50 bp from chromosome 5 (Score: 77.4, E-value: 6e-17, Gene
D: GL50803_92618/XP_001706814.1/GI:159113174, no in-
rons, named GlNMNAT-B). Although NMNAT identity for
lNMNAT-B has been attributed with bioinformatics tools and
ualitative in vitro ADH-coupled enzyme tests performed by us,
e have not included more information about this putative isoen-
yme because it is less stable in the conditions we have tested
or direct assays. For the remaining discussion, GlNMNAT-A
ill be considered as GlNMNAT.
Fig. 3 shows an alignment of the three human isoenzymes and
he two sequences found for GlNMNAT, where the ATP motifs
or recognition and binding are depicted (GxFxPx[H/T]xxH and
SSTxxR) [10]. This GlNMNAT sequences share 20–30% of
dentity with the human NMNATs and 28% between themselves.
The results of the CD database (conserved domains, NCBI)
howed that the sequence of 227 aa has the conserved domains
f nicotinamide/nicotinate mononucleotide adenylyltransferase
cd09286, E-value: 1.97e–26; cd02165, E-value: 7.03e−26).
dditionally, the InterProScan 4 (EMBL-EBI) tool revealed that
he protein is a possible nicotinamide mononucleotide adenylyl-
ransferase (PTHR12039, E-value: 3.1e–124; TIGR00482, E-
alue: 2.7e–46). The GO (gene ontology) terms predicted were
O:0009435 (NAD biosynthetic process) and GO:0016779 (nu-
leotidyltransferase activity).
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Fig. 8. Results of a direct enzyme assay using nicotinamide mononucleotide (NMN) or nicotinic acid mononucleotide (NAMN) as a substrate. NMN:
(A) Positive control (B) Negative control (C) Reaction mixture with His-GlNMNAT. NAMN: (D) Positive control (E) Negative control (F) Reaction mixture
with His-GlNMNAT.
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oUsing the I-TASSER server, a tertiary structure model was
uilt for the sequence found. Fig. 4a shows the first of the 5 mod-
ls built by the server with the best quality parameters (RMSD,
-score, and TM-score). The Rossmann-type characteristic fold
22] of proteins that bind to nucleotides (βαβαβ motif) is ob-
erved. Fig. 4b shows a 3D alignment with the tertiary struc-
ure of HsNMNAT-3 (1nuq_A, 252 aa) generated from X-ray
iffraction data (XRD) and recorded in the PDB protein struc-
ure database.
able 2
ummary of kinetic constants for ATP and NMN.
ATP NMN
RNL HW RNL HW
m (mM) 1.48 1.54 2.53 2.72
max (mM∗min−1) 9.92E-02 9.82E-02 1.21E-01 1.24E-01
cat (s−1) 2.44 2.41 2.97 3.04
cat/Km (s−1∗mM−1) 1.65 1.56 1.17 1.12
LR: non-linear regression. HWR: Hanes-Woolf regression. Temperature:
6 °C. pH: 7.5. Enzyme concentration: 6.79E-04 mM. Enzyme activity
nit: 37.3 pkat/μg.
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iSeveral structural similarities are observed in various alpha
elices and beta sheets of the overlapping proteins. Addition-
lly, the I-TASSER server showed predictions for protein func-
ion. The EC number predicted from comparisons with proteins
ecorded in the databases was 2.7.7.1/18, consistent with adeny-
yltransferase function.
Based on the above observations, an in vitro characterization
f the protein was performed. Fig. 5 shows the amplification of
he NMNAT coding region of Giardia lamblia (glnmnat) with a
ize a little larger than 650 bp, which is consistent with the value
f 684 bp reported in databases.
The amplified sequence was cloned into the expression vector
ET100/D-TOPO, which contains the upstream sequence for the
7 promoter and is inducible with IPTG. The expressed recom-
inant protein is joined at its N-terminal region by a histidine tag
o facilitate affinity purification and to perform immunodetec-
ion assays. Fig. 6 shows an SDS-PAGE gel and immunoblot-
ing of the induced protein in total cell lysate and in soluble
nd insoluble lysate fractions produced by ultrasonic pulses. All
nduced fractions show a single band with a size between 25.0
nd 35.0 kDa, which is consistent with the calculated size of
he protein of 25.4 kDa plus 4.1 kDa from the additional 36 aa
n the N-terminal region corresponding to the His-tag, the en-
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Fig. 9. GlNMNAT enzyme preparation for kinetic experiments. Purity estimated by means of densitometry using the Image J software. Enzyme enrichment
calculated taking in account the activity of the soluble fraction and the eluate. Activity in pmol∗s−1∗μg−1 or pkat∗μg−1.
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nterokinase cleavage site and the X-press epitope, for a total of
29.5 kDa. The strong band in the insoluble fraction indicates that
the recombinant protein is expressed in high amounts, folding
incorrectly and aggregating in great part.
Fig. 7 shows the results of the SDS-PAGE separation and
the immunodetection of the recombinant protein in the different
fractions obtained during partial purification from the soluble
fraction. Using nickel-affinity resin, it was possible to concen-
trate and separate the recombinant protein from most of the other
soluble proteins, with a few higher molecular weight proteins
present in the eluate. The protein was specifically detected in
the eluate by immunoblotting, with undetectable amounts of the
protein in the washes and in unbound proteins. The eluate was
used for in vitro activity assays to experimentally verify the
adenylyltransferase function of the recombinant protein. The
eluate was stored at −80 °C and supplemented with glycerol to
a concentration of 20% v/v for preservation.
Fig. 8 shows the results of the direct enzyme assay us-
ing nicotinamide mononucleotide (NMN) and nicotinic acid
mononucleotide (NAMN) as substrates. Adenylyltransferase ac-
tivity was detected with both substrates, showing the respective
production of NAD and NAAD.
Optimal pH and temperature were 7.3 and 26 °C respec-
tively (graphs not shown). Additionally, a 30 min time was
chosen for the subsequent end-point reactions (constant rate
of NAD production detected between 0 and 60 min, graph not
shown). For ATP and NMN, Michaelis–Menten curves were
obtained, but for NAMN saturation was not observed, imply-
ing that the enzyme has low affinity yet detectable activity
with this substrate in vitro. Double-reciprocal plots from NAD-
production rates varying ATP and NMN concentrations (graphs
not shown) showed no cooperativity of the enzyme. Table 2ummarizes the kinetic constants for the substrates that reached
aturation. Fig. 9 shows the enzyme preparation used for the
inetic experiments, with an estimated purity of 76% based
n densitometry and a 131-fold enrichment based on enzyme
ctivity.
In comparison with the human cytosolic isoenzyme NMNAT-
, the GlNMNAT is less efficient in terms of affinity for its sub-
trates (KmATP: 0.0889 [24], 0.107 [25], 0.204 [26]; KmNMN:
.0213 [24]) and turnover (Kcat: 8.8 [24]), hence the parasitic
eed of G. lamblia for NAD from its host despite its ability to
ynthesize it from NMN. Based on this, Giardia would use the
MN salvage pathway for NAD biosynthesis, as well as direct
ntake of this molecule from the host, discarding a priori the
alvage pathway from nicotinic acid mononucleotides and the
ore complex kynurenine pathway for de novo NAAD biosyn-
hesis which would be very demanding for such a metabolically
imited organism.
. Conclusion
From bioinformatics and experimental evidence, the iden-
ification and functional validation of nicotinamide/nicotinate
ononucleotide adenylyltransferase in Giardia lamblia (GlN-
NAT) is reported in this paper, which represents an advance
n the study of the metabolism of nicotinamide and adenine din-
cleotide (NAD) in Giardia spp.
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